Fluidigm Corporation is a public, American company engaged in the design, manufacture and sale of biological research equipment based on integrated fluidic circuit technology. In 2009, Fluidigm was described as "the worlds leading manufacturer of microfluidic devices." Among the applications to which Fluidigm products are put to use are protein crystallization, genotyping, DNA analysis and PCR. Fluidigms products leverage the capabilities of multilayer soft lithography to create microfluidic devices, specifically technology developed by one of the co-founders and branded "Integrated Fluidic Circuitry". Fluidigm is a public company traded on the NASDAQ stock exchange under the ticker symbol FLDM.